Clinical Manifestations of DIC
DIC presents with two primary clinical phenotypes: hemorrhagic manifestations characterized by oozing and difficult-to-control bleeding, and thrombotic manifestations leading to microvascular thrombosis with resultant multi-organ dysfunction. 1
Hemorrhagic Manifestations
The bleeding phenotype results from consumption of clotting factors and platelets during widespread coagulation activation. Key hemorrhagic features include:
- Oozing-type bleeding that is characteristically difficult to control
- Bleeding from multiple sites simultaneously (venipuncture sites, surgical wounds, mucosal surfaces)
- Petechiae and ecchymoses
- Gastrointestinal bleeding
- Hematuria
- Intracranial hemorrhage in severe cases
The paradox of DIC is that despite systemic coagulation activation, patients develop severe bleeding due to consumption of platelets, fibrinogen, and other clotting factors 2.
Thrombotic Manifestations
The thrombotic phenotype causes potentially devastating microvascular complications:
- Multi-organ dysfunction syndrome from widespread microvascular thrombosis affecting vital organs 3, 1
- Acute kidney injury
- Acute respiratory distress syndrome
- Hepatic dysfunction ("shock liver")
- Neurological dysfunction
- Symmetrical peripheral gangrene (SPG) - a catastrophic complication involving acral limb loss due to microvascular thrombosis in distal extremities 4
Critical Caveat on Symmetrical Peripheral Gangrene
SPG represents one of the most devastating consequences of sepsis-associated DIC. The prodromal role of acute hepatic dysfunction is particularly important, as impaired hepatic synthesis of natural anticoagulants (antithrombin and protein C) predisposes to this complication. Most patients with sepsis-associated SPG die, creating a paradoxical situation where improved mortality rates in sepsis may result in more survivors manifesting SPG 4.
Clinical Progression
DIC progresses through distinct phases 5:
- Pre-DIC/Early-phase DIC: Potentially asymptomatic with laboratory abnormalities preceding clinical symptoms (also termed subclinical or compensated DIC)
- Overt DIC: Advanced stage with clear clinical manifestations including bleeding and/or organ dysfunction
Context-Dependent Presentations
The clinical manifestations vary based on the underlying trigger:
- Sepsis-associated DIC: Characterized by suppressed fibrinolysis induced by endothelial dysfunction, rapidly progressing to multi-organ failure 4
- Trauma-related DIC: Often presents with more prominent hemorrhagic features
- Malignancy-associated DIC: May have more chronic, compensated presentations
- Obstetric DIC: Typically acute with prominent bleeding
Laboratory Correlates of Clinical Manifestations
While not strictly clinical manifestations, laboratory findings reflect the pathophysiology:
- Thrombocytopenia (platelet count <150 × 10⁹/L in sepsis-induced coagulopathy) 4
- Decreased fibrinogen levels
- Elevated D-dimer (>3× upper normal limit) 6
- Prolonged prothrombin time
- Decreased levels of natural anticoagulants (antithrombin, protein C)
Key Clinical Pitfall
The presence of an underlying disorder known to be associated with DIC is mandatory for diagnosis 3. DIC never occurs in isolation - always search for sepsis, trauma, malignancy, obstetric complications, or other triggers. The clinical manifestations must be interpreted in the context of the underlying disease, as this determines both the phenotype and management approach.